More than 100 of the area’s life science and biotechnology leaders will assemble at the PA Biotechnology Center to hear local biotech founders and executives share their success stories and insights about growing biotech opportunities.
Doylestown, PA (PRWEB) August 04, 2014
Date: Friday, Oct. 10, 2014
Time: 8:30 a.m. – 1 p.m.
Location: Pennsylvania Biotechnology Center, 3805 Old Easton Road, Doylestown, Pa.
Details: The Hepatitis B Foundation’s Baruch S. Blumberg Institute will host the 14th Annual Regional Biotech Conference, themed “Biosimilars and Biobetters.” More than 100 of the area’s life science and biotechnology leaders will assemble at the PA Biotechnology Center to hear local biotech founders and executives share their success stories and insights about growing biotech opportunities.
The following speakers and topics will be featured during the conference:
- Dr. Hung Do, Amicus – “Development of a Biobetter from Concept to Licensing and Acquisition”
- Mr. Jeffry S. Mann, Morgan, Lewis & Bockius – “The Patenting and Regulatory Aspects of Biosimilars”
About the Regional Biotech Council (RBC): The RBC is a program of the Baruch S. Blumberg Institute, the research affiliate of the Hepatitis B Foundation, and funded in part by grants from the Commonwealth of Pennsylvania. The mission of the RBC is to provide a stimulating networking environment and strategic support for biotech entrepreneurs within the five-county region of southeastern Pennsylvania – Chester, Montgomery, Delaware, Philadelphia and Bucks.
About the Baruch S. Blumberg Institute: The Baruch S. Blumberg Institute was first established in 2003 by the Hepatitis B Foundation to conduct discovery research and nurture translational biotechnology in an environment conducive to interaction, collaboration and focus. The independent, nonprofit research center was renamed in 2013 to honor the man who won the Nobel Prize for his discovery of the hepatitis B virus.
About the Hepatitis B Foundation: Headquartered in Doylestown, Pa., the Hepatitis B Foundation is the only national nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. To learn more, go to http://www.hepb.org, follow us on Twitter @HepBFoundation, find us on Facebook at http://www.facebook.com/hepbfoundation or call (215) 489-4900.
Contact: Sarah Larson at sarah(at)furiarubel(dot)com or 215-340-0480.